Sabatini Brent
SEC CIK 2037272 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | SVP, CAO | 61.9K | — | $142.1K | 9 | 2025-02-13 | 2026-06-01 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-02 17:31 | 2026-06-01 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $9.45 | -379 | 61.9K | -0.6% | -$3,582 |
| 2026-03-24 | 2026-03-23 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $9.12 | -7,711 | 61.9K | -11% | -$70.3K | |
| 2026-02-26 | 2026-02-24 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $9.53 | -1,430 | 69.6K | -2% | -$13.6K | |
| D | 2026-02-24 | 2026-02-22 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | A - Grant | $0.00 | +25.0K | 72.9K | +52% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $7.45 | -1,829 | 71.0K | -3% | -$13.6K |
| 2026-02-18 | 2026-02-13 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $7.79 | -1,530 | 47.9K | -3% | -$11.9K | |
| D | 2025-02-25 | 2025-02-24 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $9.45 | -1,562 | 46.6K | -3% | -$14.8K |
| D | 2025-02-25 | 2025-02-22 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | A - Grant | $0.00 | +20.0K | 48.2K | +71% | $0 |
| 2025-02-14 | 2025-02-13 | VIR | Vir Biotechnology, Inc. | Sabatini Brent | SVP, CAO | S - Sale | $9.15 | -1,562 | 28.2K | -5% | -$14.3K |
Purchase Sale Sale after option exercise All abbreviations